Related Companies
|
[]
|
||||||||
Related Funds
|
[]
|
||||||||
English
|
|||||||||
oda_WinningATenderAbstract|
|
|
||||||||
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
oda_DelayedAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
oda_AnnouncementContentSection|
|
|
||||||||
oda_SubjectOfTender|
|
|
Medical Microbiology Department Result Service
|
|||||||
oda_PartyOpenedTender|
|
|
Ege University
|
|||||||
oda_BoardDecisionOnBidForTender|
|
|
2024/05
|
|||||||
oda_OtherPartiesIfParticipatedInTheTenderAsAGroup|
|
|
-
|
|||||||
oda_ShareOfTheCompanyIfParticipatedInTheTenderAsAGroup|
|
|
-
|
|||||||
oda_DateOfTenderBid|
|
|
29/02/2024
|
|||||||
oda_EndingUpDateOfTheTender|
|
|
14/03/2024
|
|||||||
oda_TenderResult|
|
|
81.539.757,43 TL
|
|||||||
oda_TenderValue|
|
|
81.539.757,43 TL
|
|||||||
oda_ShareOfCompanyInTenderValue|
|
|
100%
|
|||||||
oda_RatioOfTenderValueCorporateShareAmountToGrossSalesRevenueOnPubliclyDisclosedTheLatestFinancialStatementOfCompany|
|
|
10,1161% (Rate to 2022)
|
|||||||
oda_ExplanationSection|
|
|
||||||||
oda_ExplanationTextBlock|
|
Regarding the tender issue of 81.539.757,43 TL (All) mentioned in this statement and for which we are responsible, our Company's Board of Directors has previously decided to comply with article 6 of CMB's II-15.1 Special Circumstances Communiqué with its decision dated 28/02/2024. It has decided to postpone the disclosure of inside information within the scope of article. The said postponement decision; - Public disclosure of our Company's bid for the tender "may harm our legitimate interests" in terms of competition conditions, etc. - A material event disclosure to be made at this stage may prejudice the interests of our Company and therefore our shareholders, - The deferral does not pose a risk of misleading investors, - In order to protect the confidentiality of this information during the postponement period, the matter will only be shared with the relevant persons within the company who are currently on the insider access list, and these persons have been specifically warned to respect confidentiality, It has been taken within the framework of CMB Communiqués and this announcement will be made as soon as the reasons for postponement are removed. It is respectfully announced to the public. This statement was translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail. |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.